Anti-Suicide Drugs Market to Exhibit a Rise by 4.1% CAGR Between 2019 to 2027

1. ANTI-SUICIDE DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Anti-Suicide Drugs Market - Overview The global Anti-Suicide Drugs Market, by Drug Class (Anti-Depressant and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, Antibiotic Analog), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) was valued at US$ 3,818.1 million in 2018 and is projected to expand at a CAGR of 4.1% during the forecast period (2019–2027). Introduction of novel approved drugs, expected to be commercialized post-2020, intended for treatment of suicidal ideation would be a major breakthrough for the global anti-suicide drugs market. Until recently, suicidal ideation has been treated with anti-depressants, anti-anxiety, and anti-psychotic drugs. The trend would continue until the expected launch of Cyclurad by NeruoRx Pharma during the latter half of the forecast period (2019–2027). Cyclurad is a combination of D-cycloserine and Lurasidone Ideation/Behavior (ASIB) in Bipolar Depression. Other drug candidates are also in the pipeline, intended for treatment of suicidal ideation in major depressive disorder (MDD). and indicated for Acute Suicidal Browse 48 Market Data Tables and 44 Figures spread through 150 Pages and in-depth TOC on " Anti-Suicide Drugs Market, by Drug Class (Anti-Depressant and Anti-Anxiety Drugs, Anti- Psychotic Drugs, NMDA Antagonist, Antibiotic Analog), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Forecast to 2027" Suicide is among the major economic burdens to the global economy. According to the World Health Organization (WHO), over 800,000 people commit suicide every year. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/anti- suicide-drugs-market-10 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Sneha India Foundation is also one of the major organization in India who provide 24X7 helpline in order to offers unconditional emotional support to desperate, depressed and suicidal people. High prevalence of depression that leads to suicidal attempts and deaths would be another stimulus besides the introduction of novel drugs for the growth of anti- suicide drugs market. According to the FDA, depression act as a disabling and stigmatizing illness which may lead to suicide among young people and adolescents. Thus, launch of specific drugs for suicidal impulses by pharmaceutical companies will prove to be a profitable market in the foreseen future. N-Methyl-D-aspartate receptor (NMDAR) agonists and antagonist are the prospective candidate for treating suicidal ideation. Companies banking on anti-depressants and anti-psychotic drugs for treating patients at risk for suicide should reconsider their strategy, considering these are not very effective at addressing the issue. Nonetheless, these drug class are not approved for use in treating patients at risk for suicide. The global anti-suicide drugs market has been driven majorly by off-label recommendations and prescriptions of anti-depressants, anti-anxiety and anti-psychotic drugs. Inadequate reach of healthcare facilities and affordable medications is hindering growth of overall healthcare market in emerging economies such as India, China, Brazil, and Indonesia. Therefore, companies introducing novel anti-suicidal drugs would be facing a challenge in market penetration in these nations and would be able to capture only a part of these markets to capitalize on the lucrative growth opportunities in these regions. North America and Europe remain potential markets at initial stages for the anti-suicidal drugs. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/10 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key takeaways of the market: The global anti-suicide drugs market is majorly characterized by the use of anti-depressants, anti-anxiety and anti-psychotic drugs The global anti-suicide drugs market is expected to expand at a CAGR of 4.1% during the forecast period (2019–2027). Rising incidence of suicides across the globe is expected to favor the market growth for anti-suicide drugs over the forecast period. Suicidal rates are higher in Asia, Eastern Europe and Africa regions The antibiotic analog (NMDA agonist) segment in the global anti-suicide drugs market is estimated to be growing faster post its FDA approval and commercialization Market growth for anti-depressants and anti-anxiety drugs is projected to be impacted negatively by the launch of FDA approved anti-suicidal drugs expected towards the latter-half of the forecast period Some of the major players present in the global anti-suicide drugs market are Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., and Johnson & Johnson Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/10 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved